Financial & competing interests disclosure
In the last 5 years, ZJ Daskalakis received external funding through Brainsway Inc. and a travel allowance through Pfizer and Merck. ZJ Daskalakis has also received speaker funding through Sepracor Inc. and AstraZeneca, and has served on the advisory board for Hoffmann-La Roche Ltd. This work was supported by the Ontario Mental Health Foundation, the Canadian Institutes of Health Research, the Brain and Behaviour Research Foundation, the Temerty Family, the Grant Family, the Centre for Addiction and Mental Health Foundation and the Campbell Institute. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript.
No writing assistance was utilized in the production of this manuscript.